Evolution of Clinical Research: Reflections from DIA Conferences The evolution of clinical research is clearly visible at the DIA Annual Conference. My first DIA was in 1997 in Montreal, and each year since has offered a snapshot of how the industry continues to change. Viewed over time, DIA tells a story of advancing technologies, shifting… Read more »
News & Events
The May 2023 FOCM | GLSA Networking Event
Clinical Trial Funding Strategy Insights: May 17, 2023 GLSA Networking Event Event Date: May 17, 2023 Clinical trial funding strategy was the focus of the May 17, 2023 GLSA networking event. As always, our goal was to connect people and companies we know and respect to foster meaningful collaboration. To support ongoing conversations, attendees were… Read more »
The April 2023 FOCM | GLSA Networking Event
Philippines Clinical Trials Spotlight: April 19, 2023 GLSA Networking Event Event Date: April 19, 2023 The Philippines clinical trials landscape was the focus of the April FOCM | GLSA Networking Event. The session opened with a warm welcome and an introduction of the featured presenter, Joseph Cheng of PiVOT, who immediately engaged attendees with a… Read more »
The March 2023 FOCM | GLSA Networking event
Clinical Trial Recruitment Innovation: March 15, 2023 GLSA Networking Event Event Date: March 15, 2023 The March FOCM | GLSA Networking Event highlighted clinical trial recruitment innovation and patient-centric technology. The session opened with a welcome to attendees and a reminder of GLSA’s collaborative, open-house format designed to foster meaningful connections across the clinical research… Read more »
The January 2023 FOCM | GLSA Networking Event
Cold Chain Logistics in Clinical Trials | January 2023 GLSA Networking Event Cold chain logistics in clinical trials was the focus of the January 18, 2023 FOCM | GLSA Networking Event. To begin, attendees were welcomed and wished a Happy New Year as the group gathered for the first event of the year. At the… Read more »
Clinical Trials in the Philippines: A Strategic Advantage for Global Studies
Global Reach for Clinical Trials: Why the Philippines Is a Strategic Advantage GLSA offers global reach for clinical trials through our trusted network of Clinical Research Organizations (CROs). In particular, this article highlights the advantages of conducting clinical trials in the Philippines—a region that continues to emerge as a strategic hub for XUS studies. Through… Read more »
The December 2022 FOCM | GLSA Networking Event
December FOCM | GLSA Networking Event Recap The December FOCM | GLSA networking event kicked off with a warm welcome and a brief overview of how these gatherings work. For newcomers, the event follows an open-house format—participants are welcome to drop in when they can and leave as needed. Typically, featured topics and presenters begin… Read more »
The September 2022 GLSA | FOCM Networking Event
Digital 1st CRO Model: Validcare at the September GLSA | FOCM Networking Event The GLSA | FOCM Networking Event on September 21, 2022, featured a compelling presentation from Patrick McCarthy and Steve Galen of Validcare on the Digital 1st CRO model and why it represents a meaningful shift in how clinical trials are conducted. Advances… Read more »
The August 2022 GLSA | FOCM Networking Event
Life Sciences Networking Event: GLSA August 2022 Recap The GLSA | FOCM Networking Event on August 17, 2022, was intentionally lighter in attendance, as many colleagues across the life sciences industry took advantage of the summer months for a well-deserved break. Even so, the discussion delivered valuable insights and practical takeaways for sponsors and service… Read more »
Conference Report: DIA Annual Meeting | Chicago, IL June 2022
A Return to Networking: DIA 2022 Signals a Reawakening of In-Person Collaboration The DIA 2022 networking event marked a long-awaited return to in-person engagement for the life sciences industry. For many attendees, this was the first opportunity to reconnect face-to-face since the last DIA Annual Conference in San Diego in June 2019. As a result,… Read more »